On-target comments, Alleyba. What Zacks has done is, in effect, to single out Scrips as a special case worthy of close attention, considering the still low share price, together with the prospect of substantial growth in earnings – actually likely to reach a level well above Zacks' conservative estimate. The Zacks analysts have left themselves room to raise their initial "hold" to "buy" if growth in 2015 works out as most of us here are expecting. It all looks good to me...